I. Ahmad

发表

Negative mpMRI Rules Out Extra-Prostatic Extension in Prostate Cancer before Robot-Assisted Radical Prostatectomy

John P. Mulligan, A. Freeman, S. Punwani, 2022, Diagnostics.

Feasibility and safety of radical prostatectomy for oligo‐metastatic prostate cancer: the Testing Radical prostatectomy in men with prostate cancer and oligo‐Metastases to the bone (TRoMbone) trial

F. Hamdy, J. Donovan, N. Hassanali, 2022 .

NeuroSAFE PROOF: study protocol for a single-blinded, IDEAL stage 3, multi-centre, randomised controlled trial of NeuroSAFE robotic-assisted radical prostatectomy versus standard robotic-assisted radical prostatectomy in men with localized prostate cancer

J. Oxley, A. Freeman, S. Mallett, 2022, Trials.

Effect of Robot-Assisted Radical Cystectomy With Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients With Bladder Cancer: A Randomized Clinical Trial.

A. Feber, Muhammad S. Khan, N. Vasdev, 2022, JAMA.

The Scottish Bladder Cancer Quality Performance Indicators Influencing Outcomes, Prognosis, and Surveillance (Scot BC Quality OPS) Clinical Project.

L. Makaroff, J. Norrie, N. Vasdev, 2021, European urology focus.

Clinical and prostate multiparametric magnetic resonance imaging findings as predictors of general and clinically significant prostate cancer risk: A retrospective single-center study

F. Crocetto, B. Barone, J. Bhatt, 2023, Current Urology.

Multicentre real world long-term outcomes in 2773 primary Non-Muscle Invasive Bladder Cancer (NMIBC) patients managed within the Scottish Bladder Cancer Quality Performance Indicator programme

P. Mariappan, J. Bhatt, A. Chaudhry, 2022, European Urology.

Feasibility and safety of radical prostatectomy for oligo‐metastatic prostate cancer: the Testing Radical prostatectomy in men with prostate cancer and oligo‐Metastases to the bone (TRoMbone) trial

F. Hamdy, N. Hassanali, P. Sooriakumaran, 2021, BJU international.